P-269 - PET/TC-PSMA RESULTS AFTER RADICAL-PROSTATECTOMY: RECURRENCE PATTERNS AND IMPLICATIONS ON TREATMENT

P-270 - PET-TC-PSMA+MRI IN THE DETECTION OF LOCAL RECURRENCE AFTER RADICAL PROSTATECTOMY

P-275 - POST-OPERATIVE HIPOFRACTIONATED RADIOTHERAPY IN PROSTATE CANCER.

P-276 - POSTOPERATIVE RADIATIOTHERAPY IN PROSTATE CANCER.

P-282 - PREDICTIVE FACTORS OF POSITIVE RESULT FOR 68Ga-PSMA AFTER RADICAL PROSTATECTOMY.

P-291 - PROFILE OF PATIENTS TREATED WITH APALUTAMIDE. A SINGLE CENTER EXPERIENCE.

P-295 - PROSTATE CANCER INCIDENCE WILL DESCEND IN THE NEAR FUTURE.

P-296 - PROSTATE CANCER PATIENTS TREATED WITH HYPOFRACTIONATED PELVIC RADIATION THERAPY

P-297 - PROSTATE SBRT? YES YOU CAN

P-298 - PROSTATIC BED INTRAOPERATIVE RADIOTHERAPY (IORT): VIABILITY AND TECHNICAL ASPECTS

P-300 - PSA RESPONSE AFTER SBRT IN PROSTATE CANCER

P-301 - PSMA AND CHOLINE PET/CT PROSTATE CANCER PATIENTS EVALUATED FOR RADIOTHERAPY

P-314 - RADIOTHERAPY IN LYMPH NODE OLIGORECURRENT PROSTATE CANCER

P-328 - RELAPSE PATTERN IN PROSTATE CANCER AFTER SALVAGE RADIOTHERAPY. ONE-CENTER EXPERIENCE.

P-330 - RESPONSE TO ENZALUTAMIDE AFTER RADIOTHERAPY FOR PROSTATE CANCER

P-340 - SABR IN METASTATIC PROSTATE CANCER PATIENTS WITH OLIGORECURRENCE

P-343 - SALVAGE RADIOTHERAPY AFTER CRYOTHERAPY IN PROSTATE CANCER

P-344 - SALVAGE RADIOTHERAPY IN PATIENTS WITH BIOCHEMICAL RELAPSE AFTER RADICAL PROSTATECTOMY

P-345 - SALVAGE SBRT FOR OLIGORECURRENT LYMPH NODE PROSTATE CANCER METASTASES.

P-351 - SBRT FOR LYMPH NODE OLIGOMETASTASES FROM PROSTATE CANCER

P-352 - SBRT FOR TREATMENT OF OLIGOMETASTATIC PROSTATE CANCER